1. Home
  2. AROW vs TBPH Comparison

AROW vs TBPH Comparison

Compare AROW & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • TBPH
  • Stock Information
  • Founded
  • AROW 1851
  • TBPH 2013
  • Country
  • AROW United States
  • TBPH United States
  • Employees
  • AROW N/A
  • TBPH N/A
  • Industry
  • AROW Major Banks
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROW Finance
  • TBPH Health Care
  • Exchange
  • AROW Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • AROW 463.7M
  • TBPH 467.0M
  • IPO Year
  • AROW N/A
  • TBPH N/A
  • Fundamental
  • Price
  • AROW $25.88
  • TBPH $9.28
  • Analyst Decision
  • AROW Hold
  • TBPH Buy
  • Analyst Count
  • AROW 1
  • TBPH 4
  • Target Price
  • AROW $30.00
  • TBPH $13.75
  • AVG Volume (30 Days)
  • AROW 35.3K
  • TBPH 297.6K
  • Earning Date
  • AROW 04-29-2025
  • TBPH 05-12-2025
  • Dividend Yield
  • AROW 4.32%
  • TBPH N/A
  • EPS Growth
  • AROW 0.27
  • TBPH N/A
  • EPS
  • AROW 1.77
  • TBPH N/A
  • Revenue
  • AROW $134,626,000.00
  • TBPH $64,381,000.00
  • Revenue This Year
  • AROW $23.17
  • TBPH $39.34
  • Revenue Next Year
  • AROW $7.29
  • TBPH $3.63
  • P/E Ratio
  • AROW $14.66
  • TBPH N/A
  • Revenue Growth
  • AROW 3.11
  • TBPH 12.12
  • 52 Week Low
  • AROW $21.50
  • TBPH $7.44
  • 52 Week High
  • AROW $34.63
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • AROW 40.18
  • TBPH 48.06
  • Support Level
  • AROW $25.10
  • TBPH $9.12
  • Resistance Level
  • AROW $26.52
  • TBPH $9.52
  • Average True Range (ATR)
  • AROW 0.74
  • TBPH 0.41
  • MACD
  • AROW -0.04
  • TBPH 0.00
  • Stochastic Oscillator
  • AROW 35.94
  • TBPH 35.46

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. The company provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: